As of 2024-12-14, the EV/EBITDA ratio of CureVac NV (CVAC) is 1.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CVAC's latest enterprise value is 172.54 mil USD. CVAC's TTM EBITDA according to its financial statements is 152.70 mil USD. Dividing these 2 quantities gives us the above CVAC EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 41.5x | 26.6x |
| Forward P/E multiples | 11.6x - 17.0x | 14.3x |
| Fair Price | 10.68 - 32.06 | 17.03 |
| Upside | 238.1% - 914.5% | 438.8% |
| Date | EV/EBITDA |
| 2024-12-13 | 1.08 |
| 2024-12-12 | 1.13 |
| 2024-12-11 | 1.22 |
| 2024-12-10 | 1.15 |
| 2024-12-09 | 1.37 |
| 2024-12-06 | 0.99 |
| 2024-12-05 | 0.91 |
| 2024-12-04 | 0.70 |
| 2024-12-03 | 0.64 |
| 2024-12-02 | 0.74 |
| 2024-11-29 | 0.67 |
| 2024-11-27 | 0.67 |
| 2024-11-26 | 0.49 |
| 2024-11-25 | 0.53 |
| 2024-11-22 | 0.38 |
| 2024-11-21 | 0.24 |
| 2024-11-20 | 0.14 |
| 2024-11-19 | 0.15 |
| 2024-11-18 | 0.26 |
| 2024-11-15 | 0.21 |
| 2024-11-14 | 0.39 |
| 2024-11-13 | 0.50 |
| 2024-11-12 | 0.68 |
| 2024-11-11 | 0.56 |
| 2024-11-08 | 0.63 |
| 2024-11-07 | 0.61 |
| 2024-11-06 | 0.66 |
| 2024-11-05 | 0.75 |
| 2024-11-04 | 0.45 |
| 2024-11-01 | 0.52 |
| 2024-10-31 | 0.49 |
| 2024-10-30 | 0.57 |
| 2024-10-29 | 0.70 |
| 2024-10-28 | 0.61 |
| 2024-10-25 | 0.50 |
| 2024-10-24 | 0.46 |
| 2024-10-23 | 0.43 |
| 2024-10-22 | 0.50 |
| 2024-10-21 | 0.53 |
| 2024-10-18 | 0.57 |
| 2024-10-17 | 0.60 |
| 2024-10-16 | 0.63 |
| 2024-10-15 | 0.59 |
| 2024-10-14 | 0.60 |
| 2024-10-11 | 0.73 |
| 2024-10-10 | 0.67 |
| 2024-10-09 | 0.73 |
| 2024-10-08 | 0.70 |
| 2024-10-07 | 0.82 |
| 2024-10-04 | 0.88 |